USA: Biopharmaceuticals Alnylam Pharmaceuticals to Build new Biopharma–Manufacturing in the US
Alnylam Pharmaceuticals has chosen Jacobs Engineering to provide provide engineering services and procurement for its new manufacturing facility in Norton, Massachusetts.
Norton, Massachusetts/USA –Jacobs provides engineering services and procurement for the multi-product facility being built to supply RNA interference-based therapeutics for clinical and commercial needs. The 200,000 square foot facility is expected to be completed in 2018.
In making the announcement, Jacobs Senior Vice President Global Life Sciences Robert Norfleet stated, “Partnering with Alnylam on this major development that enables the company to realize its goal of becoming a fully integrated, commercial-stage company is an exciting opportunity. We’re proud Alnylam turned to Jacobs as its design partner, and we look forward to delivering a state- of- the-art facility.”